QED-121
Autoimmune diseases (e.g., systemic lupus erythematosus)
PreclinicalActive
Key Facts
Indication
Autoimmune diseases (e.g., systemic lupus erythematosus)
Phase
Preclinical
Status
Active
Company
About Lucia Bio
Australian‑focused biotech creating next‑generation oral Syk inhibitors for autoimmune, neuroinflammatory and oncology markets.
View full company profile